Related Experiment Video
Updated: Apr 20, 2026

Translating Ribosome Affinity Purification TRAP for RNA Isolation from Endothelial Cells In Vivo
Published on: May 25, 2019
Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study
Chiara Briani1, Chiara Dalla Torre1, Federica Lessi2
1Department of Neurosciences, Sciences NPSRR, University of Padova, Italy.
Abstract:
Circulating Pentraxin 3 (PTX3) and vascular endothelial growth factor (VEGF) levels were measured longitudinally (mean follow-up 2 years) by ELISA in 6 patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes (POEMS) syndrome and 16 controls. Expression of PTX3 was also assessed (immunohistochemistry) on sural nerve biopsies from POEMS and vasculitic neuropathy patients. No correlation was found between PTX3 and VEGF levels in POEMS or controls. Sural nerve biopsies from vasculitic neuropathy patients, but not those from POEMS syndrome, showed strong PTX3 staining. PTX3, expression of vessel inflammation/remodeling, and VEGF, crucial pro-angiogenic cytokine, appear to be independently regulated in POEMS syndrome.

